3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pituitary Neoplasms
7
Acromegaly
4
Prostatic Neoplasms
3
Carcinoid Tumor
3
Pituitary ACTH Hypersecretion
2
Pancreatic Neoplasms
2
Neuroendocrine Tumors
2
Neoplasms
2
Growth Disorders
2
Gigantism
2
Carcinoma, Hepatocellular
2
Uveal Melanoma
1
Thyroid Neoplasms
1
Serotonin Syndrome
1
Prolactinoma
1
Primary Inoperable Thymoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroectodermal Tumors, Primitive
1
Neoplasm Metastasis
1
Nelson Syndrome
1
Myelodysplastic Syndromes
1
Meningioma
1
Melanoma
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hematologic Neoplasms
1
Gastro-enteropancreatic neuroendocrine tumor
1
Dumping Syndrome
1
Interventions
Temozolomide
2
Everolimus
2
Capecitabine
2
Bevacizumab
2
regorafenib
1
pazopanib
1
motesanib diphosphate
1
batifiban
1
Sorafenib
1
Panobinostat
1
Oxaliplatin
1
Octreotide
1
Leucovorin
1
Fluorouracil
1
Fentanyl
1
Doxorubicin
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Insulinoma
×
pasireotide
×
Clear all
No trials found.